WMSA
ACHN

Weiss Multi-Strategy Advisers’s Achillion Pharmaceuticals ACHN Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-50,000
Closed -$151K – 1169
2013
Q3 		$151K Buy
50,000
+40,000
+400% +$274K ﹤0.01% 877
2013
Q2 		$82K Buy
+10,000
New +$76.3K ﹤0.01% 732

Weiss Multi-Strategy Advisers's ACHN Position: Q1 2020 in Review

Weiss Multi-Strategy Advisers sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 2,848,261 shares — an estimated $17.2M sold.

Weiss Multi-Strategy Advisers first reported a position in ACHN in Q2 2013 and held it in 8 quarters. The position peaked at $17.2M in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

  • Weiss Multi-Strategy Advisers reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 2,848,261 Achillion Pharmaceuticals shares in Q1 2020, an estimated $17.2M.
  • Weiss Multi-Strategy Advisers first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 8 quarters.
  • Weiss Multi-Strategy Advisers's Achillion Pharmaceuticals position peaked at $17.2M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2020, filed 15 May 2020.